Home/Filings/4/0001250853-18-000151
4//SEC Filing

Forman Stephen J. 4

Accession 0001250853-18-000151

CIK 0001335105other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 8:03 PM ET

Size

7.8 KB

Accession

0001250853-18-000151

Insider Transaction Report

Form 4
Period: 2018-12-07
Transactions
  • Purchase

    Common Stock

    2018-12-07$0.50/sh+100,000$50,000100,000 total(indirect: By Trust)
  • Purchase

    Warrants to Purchase Common Stock

    2018-12-07$0.50/sh+100,000$50,000100,000 total(indirect: By Trust)
    Exercise: $1.00From: 2018-12-07Exp: 2022-12-07Common Stock (100,000 underlying)
Holdings
  • Common Stock

    22,500
Footnotes (1)
  • [F1]The reporting person acquired 100,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50 per Unit.

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1
  • filerCIK 0001676461

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:03 PM ET
Size
7.8 KB